106 results on '"Elshaboury, Ramy"'
Search Results
2. Evaluating Clinical Sequelae of the Carbapenem-Valproate Interaction: A Retrospective Analysis.
3. 845. Clinical Outcomes in Patients Treated with High vs. Standard Dose Liposomal Amphotericin B for Invasive Mucormycosis
4. Should cefepime be used for any bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Enterobacterales?
5. Artemisinin
6. Nifurtimox
7. Miltefosine
8. Eflornithine
9. List of Contributors
10. Benznidazole
11. Praziquantel
12. Carbapenem-resistant Enterobacterales susceptibility patterns to new antimicrobials: A single-center analysis
13. Addressing Inpatient Beta-Lactam Allergies: A Multihospital Implementation
14. 1155. Short vs. Long Symptom Duration Prior to Remdesivir for Hospitalized Patients with COVID-19
15. 1992. Risk of Infective Endocarditis in Streptococcal mitis Bloodstream Infections Among Patients with Neutropenia from Hematologic Malignancies
16. A Case Series of Rifabutin Use in Staphylococcal Prosthetic Infections
17. Pharmacodynamics of Fluoroquinolones
18. Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study
19. 793. Rifabutin Use in Staphylococcal Prosthetic Material Infections: A Case Series
20. Multisociety statement on coronavirus disease 2019 (COVID-19) vaccination as a condition of employment for healthcare personnel
21. sj-pdf-1-tai-10.1177_20499361211046669 – Supplemental material for Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization period
22. Beta-lactam antibiotic test doses in the emergency department
23. 175 - Praziquantel
24. 163 - Artemisinin
25. Therapeutic drug monitoring of flucytosine in a cardiac transplant patient receiving continuous veno‐venous hemofiltration and intermittent hemodialysis: A case report
26. Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization period
27. Carbapenem-resistant Enterobacterales susceptibility patterns to new antimicrobials: A single-center analysis.
28. 61. Evaluation of the Impact of a Micafungin Time-Out Protocol for Hospitalized Patients
29. 1482. Local validation of the drug resistance in pneumonia clinical prediction score at a large academic medical center and a community hospital
30. Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19
31. Assessment and Optimization of the Empiric Treatment of Urinary Tract Infections in an Academic Emergency Department Observation Unit
32. 756. Impact of Infectious Diseases Pharmacists as Part of an Interdisciplinary OPAT Team Managing Vancomycin
33. Outcomes from an inpatient beta-lactam allergy guideline across a large US health system
34. Outcomes of beta-lactam antibiotic test dose procedures for patients with reported beta-lactam allergy performed in a large US healthcare system
35. Therapeutic drug concentrations of isavuconazole following the administration of isavuconazonium sulfate capsules via gastro‐jejunum tube: A case report
36. A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-Susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable mecA by a Commercial PCR Assay Compared to Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Isolates
37. Multisociety statement on coronavirus disease 2019 (COVID-19) vaccination as a condition of employment for healthcare personnel
38. Recurrent Relatively Resistant Salmonella infantis Infection in 2 Immunocompromised Hosts Cleared With Prolonged Antibiotics and Fecal Microbiota Transplantation
39. I.V. push administration of medications reconstituted with 0.9% sodium chloride injection
40. HCV Therapy Follow-up Fractionation (CTF2) by Intra-PBMC Nested RNA PCR Recognizes Early Virologic Response and Relapse
41. A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-Susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable mecA by a Commercial PCR Assay Compared to Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Isolates
42. 171 - Nifurtimox
43. 170 - Miltefosine
44. 167 - Eflornithine
45. 164 - Benznidazole
46. Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration
47. Results of a local combination therapy antibiogram for Pseudomonas aeruginosa isolates: is double worth the trouble?
48. Prospective evaluation of a continuous infusion vancomycin dosing nomogram in critically ill patients undergoing continuous venovenous haemofiltration.
49. Fecal Microbiota Transplantation and Emerging Treatments for Clostridium difficile Infection
50. Results of a local combination therapy antibiogram for Pseudomonas aeruginosaisolates: is double worth the trouble?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.